|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 513.8 CHF | -1.72% |
|
+0.71% | +45.26% |
| Apr. 18 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... |  |
| Apr. 18 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
ZURICH (Reuters) - Lonza is investing in new drug product manufacturing capacity at its site in Guangzhou, China, the Swiss company said on Monday.
The sterile, multi-product fill and finish line is expected to be completed in 2022 and will create more than 150 jobs. Lonza, which has been making ingredients for Moderna's COVID-19 vaccine, did not say how much it was spending on the Guangzhou plant.
(Reporting by John Revill; Editing by Michael Shields)
| 1st Jan change | Capi. | |
|---|---|---|
| +45.26% | 41.25B | |
| +1.12% | 43.84B | |
| +6.77% | 41.68B | |
| -11.96% | 27.04B | |
| +6.01% | 25.53B | |
| -24.92% | 18.18B | |
| -3.63% | 12.29B | |
| +27.16% | 12.29B | |
| +7.30% | 11.15B | |
| -18.79% | 9.98B |
LONZA GROUP AG 
